Where we're up to


Click image to enlarge

ADAC Adult V4 is live!

What to expect with the new version of ADAC:

  1. New topic list including Treatment related toxicities and management
  2. Two exit points (Safe handling of hazardous drugs and related waste and Administering anti-cancer drugs) with related assessment strategies including eQuiz, Supervised clinical practice, Clinical skill workshop and Competency assessment.
  3. New workbook with key summary notes and activities
  4. Enhanced design elements, including animations, case studies, real clinical images and videos
  5. New competency system assessing the learner from dependent through to independent with level 6 representing advanced practice level – an option for facilities who wish to recognise staff capable of performing the facilitator or assessor role.

Key module changes:

Module 1: Safe handling of hazardous drugs and related waste

There have been some exciting additions to Module 1 including;

  1. Brand new topic defining categories of hazardous drugs using NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings
  2. New section on control measures, using the hierarchy of control, including PPE.
  3. New risk management process of hazardous drugs including learning activity and workplace focus to contextualise local practice.
  4. New video! Hazardous drug spill management

Module 2: Understanding how anti-cancer drugs work 

Module 2 is dedicated to different drug classes classifications and their mechanisms of action including targeted therapies, monoclonal antibodies, immune checkpoint inhibitors and hormonal therapies, not just cytotoxic drugs.  

  1. Brand new content:
    1. Targeted therapies, including small molecule drugs and monoclonal antibodies
    2. Principles of anti-cancer drugs treatment, including drug classes, combination treatment and scheduling
    3. Immunotherapies, including immune checkpoint inhibitors 
    4. Hormonal therapies 
    5. Drug interactions.
  2. New animations to explain the mechanisms of action of different agents  
  3. Case study exploring different classes of drugs in a treatment protocol.

Module 3: Treatment related toxicities and management 

Module 3 is totally new and focusses on treatment related toxicities and their management. 

  • Comprehensive toxicities list is categorised according to body system and aligns with eviQ clinical resources 
  • Each toxicities include basic pathophysiology, management and patient education  
  • Each body system is separated into a content block for easy access and revisit 
  • New adverse events section including hypersensitivity reaction and oncological emergencies 

Module 4: Reviewing anti-cancer protocols and prescriptions 

  • New content! 
    • Principle of medication safety and practice
    • Clinical trials in the treatment of cancer including principle, phases and ethical consideration 
  • Nursing verification process using treatment protocol and medication chart 
  • Drug dose calculation including BSA based, AUC and carboplatin dose, dose escalation and dose modification   
  • Case study with nursing verification and dose calculation  

Module 5: Patient education   

New learning activity!

- Interactive case study featuring patient/nurse drag and drop activity to prepare the learner to deliver patient education. 

Module 6: Patient assessment

Brand new;

  • case study activity with role play and toxicities assessment 

  • overview of patient-reported outcome measures (PROMs)

  • Toxicity management including escalation, dose modification and cumulative toxicities 

Module 7: Administering anti-cancer drugs

Modules 6 and 7 from version 3 have been combined to make one module - module 7.

This module now includes all routes (not just orals) and has more flexibility – learners are only required to complete the eLearning and assessment on the route/s they administer. Learners can add other routes at a later stage.    

Training and resources for facilitators 

Ongoing training and resources are now available for facilitators. Please visit the Facilitator Toolbox and training calendar for more information. 

Thank you to our reviewers

We would like to thank our clinical advisory committee and external review group for generously giving their time and expertise to improve this course.

Clinical advisory committee

Alexandra Merry Hannah McCormick Sandra Ridings
Clare Jeans Leisa Brown-West Susanne Brooks
Courtney Morgan (NDHB) Lindsay Adriaansen Suzanne Bartlett
Emma Bond Matthew Cupitt Suzzanna Fettell
Erin Shooter Michelle Weston Verity Gotch
Fiona Sayer  Robyn McIntyre Wendy Jar 
Georgina Clark    

Meet our subject matter expert: Sarah Chung

Sarah Chung

Sarah Chung is a Clinical Nurse Specialist in Haematology at St George Hospital, and has over a decade of experience caring for people with cancer. 

She joined the eviQ Education team in 2016 to review content and lead the update of the Anti-cancer Drug Administration course and is managing the current version four release. 


Learn more about eviQ Education